ENTRY       mmu05225                    Pathway
NAME        Hepatocellular carcinoma - Mus musculus (mouse)
DESCRIPTION Hepatocellular carcinoma (HCC) is a major type of primary liver cancer and one of the rare human neoplasms etiologically linked to viral factors. It has been shown that, after HBV/HCV infection and alcohol or aflatoxin B1 exposure, genetic and epigenetic changes occur. The recurrent mutated genes were found to be highly enriched in multiple key driver signaling processes, including telomere maintenance, TP53, cell cycle regulation, the Wnt/beta-catenin pathway (CTNNB1 and AXIN1), the phosphatidylinositol-3 kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway. Recent studies using whole-exome sequencing have revealed recurrent mutations in new driver genes involved in the chromatin remodelling (ARID1A and ARID2) and the oxidative stress (NFE2L2) pathways.
CLASS       Human Diseases; Cancer: specific types
PATHWAY_MAP mmu05225  Hepatocellular carcinoma
ORGANISM    Mus musculus (mouse) [GN:mmu]
GENE        21802  Tgfa; transforming growth factor alpha [KO:K08774]
            13649  Egfr; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]
            16002  Igf2; insulin-like growth factor 2 [KO:K13769]
            16001  Igf1r; insulin-like growth factor I receptor [KO:K05087] [EC:2.7.10.1]
            18803  Plcg1; phospholipase C, gamma 1 [KO:K01116] [EC:3.1.4.11]
            234779  Plcg2; phospholipase C, gamma 2 [KO:K05859] [EC:3.1.4.11]
            18750  Prkca; protein kinase C, alpha [KO:K02677] [EC:2.7.11.13]
            18751  Prkcb; protein kinase C, beta [KO:K19662] [EC:2.7.11.13]
            18752  Prkcg; protein kinase C, gamma [KO:K19663] [EC:2.7.11.13]
            13712  Elk1; ELK1, member of ETS oncogene family [KO:K04375]
            20416  Shc1; src homology 2 domain-containing transforming protein C1 [KO:K06279]
            216148  Shc2; SHC (Src homology 2 domain containing) transforming protein 2 [KO:K17447]
            20418  Shc3; src homology 2 domain-containing transforming protein C3 [KO:K17448]
            271849  Shc4; SHC (Src homology 2 domain containing) family, member 4 [KO:K17449]
            14784  Grb2; growth factor receptor bound protein 2 [KO:K04364]
            20662  Sos1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099]
            20663  Sos2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099]
            15461  Hras; Harvey rat sarcoma virus oncogene [KO:K02833]
            16653  Kras; Kirsten rat sarcoma viral oncogene homolog [KO:K07827]
            18176  Nras; neuroblastoma ras oncogene [KO:K07828]
            11836  Araf; Araf proto-oncogene, serine/threonine kinase [KO:K08845] [EC:2.7.11.1]
            109880  Braf; Braf transforming gene [KO:K04365] [EC:2.7.11.1]
            110157  Raf1; v-raf-leukemia viral oncogene 1 [KO:K04366] [EC:2.7.11.1]
            26395  Map2k1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
            26396  Map2k2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
            26413  Mapk1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
            26417  Mapk3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
            18706  Pik3ca; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]
            18707  Pik3cd; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]
            74769  Pik3cb; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]
            18709  Pik3r2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]
            18708  Pik3r1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]
            18710  Pik3r3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]
            19211  Pten; phosphatase and tensin homolog [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]
            11651  Akt1; thymoma viral proto-oncogene 1 [KO:K04456] [EC:2.7.11.1]
            11652  Akt2; thymoma viral proto-oncogene 2 [KO:K04456] [EC:2.7.11.1]
            23797  Akt3; thymoma viral proto-oncogene 3 [KO:K04456] [EC:2.7.11.1]
            56717  Mtor; mechanistic target of rapamycin kinase [KO:K07203] [EC:2.7.11.1]
            58988  Rps6kb2; ribosomal protein S6 kinase, polypeptide 2 [KO:K04688] [EC:2.7.11.1]
            72508  Rps6kb1; ribosomal protein S6 kinase, polypeptide 1 [KO:K04688] [EC:2.7.11.1]
            12015  Bad; BCL2-associated agonist of cell death [KO:K02158]
            12048  Bcl2l1; BCL2-like 1 [KO:K04570]
            17869  Myc; myelocytomatosis oncogene [KO:K04377]
            19645  Rb1; RB transcriptional corepressor 1 [KO:K06618]
            13555  E2f1; E2F transcription factor 1 [KO:K17454]
            242705  E2f2; E2F transcription factor 2 [KO:K09389]
            13557  E2f3; E2F transcription factor 3 [KO:K06620]
            21752  Tert; telomerase reverse transcriptase [KO:K11126] [EC:2.7.7.49]
            21748  Terc; telomerase RNA component [KO:K22183]
            22059  Trp53; transformation related protein 53 [KO:K04451]
            12575  Cdkn1a; cyclin-dependent kinase inhibitor 1A (P21) [KO:K06625]
            13197  Gadd45a; growth arrest and DNA-damage-inducible 45 alpha [KO:K04402]
            17873  Gadd45b; growth arrest and DNA-damage-inducible 45 beta [KO:K04402]
            23882  Gadd45g; growth arrest and DNA-damage-inducible 45 gamma [KO:K04402]
            12028  Bax; BCL2-associated X protein [KO:K02159]
            12018  Bak1; BCL2-antagonist/killer 1 [KO:K14021]
            107986  Ddb2; damage specific DNA binding protein 2 [KO:K10140]
            27015  Polk; polymerase (DNA directed), kappa [KO:K03511] [EC:2.7.7.7]
            12578  Cdkn2a; cyclin dependent kinase inhibitor 2A [KO:K06621]
            12567  Cdk4; cyclin-dependent kinase 4 [KO:K02089] [EC:2.7.11.22]
            12571  Cdk6; cyclin-dependent kinase 6 [KO:K02091] [EC:2.7.11.22]
            12443  Ccnd1; cyclin D1 [KO:K04503]
            21803  Tgfb1; transforming growth factor, beta 1 [KO:K13375]
            21808  Tgfb2; transforming growth factor, beta 2 [KO:K13376]
            21809  Tgfb3; transforming growth factor, beta 3 [KO:K13377]
            21812  Tgfbr1; transforming growth factor, beta receptor I [KO:K04674] [EC:2.7.11.30]
            21813  Tgfbr2; transforming growth factor, beta receptor II [KO:K04388] [EC:2.7.11.30]
            17126  Smad2; SMAD family member 2 [KO:K04500]
            17127  Smad3; SMAD family member 3 [KO:K23605]
            17128  Smad4; SMAD family member 4 [KO:K04501]
            22408  Wnt1; wingless-type MMTV integration site family, member 1 [KO:K03209]
            22413  Wnt2; wingless-type MMTV integration site family, member 2 [KO:K00182]
            22414  Wnt2b; wingless-type MMTV integration site family, member 2B [KO:K00182]
            22415  Wnt3; wingless-type MMTV integration site family, member 3 [KO:K00312]
            22416  Wnt3a; wingless-type MMTV integration site family, member 3A [KO:K00312]
            22417  Wnt4; wingless-type MMTV integration site family, member 4 [KO:K00408]
            22418  Wnt5a; wingless-type MMTV integration site family, member 5A [KO:K00444]
            22419  Wnt5b; wingless-type MMTV integration site family, member 5B [KO:K00444]
            22420  Wnt6; wingless-type MMTV integration site family, member 6 [KO:K00445]
            22421  Wnt7a; wingless-type MMTV integration site family, member 7A [KO:K00572]
            22422  Wnt7b; wingless-type MMTV integration site family, member 7B [KO:K00572]
            20890  Wnt8a; wingless-type MMTV integration site family, member 8A [KO:K00714]
            22423  Wnt8b; wingless-type MMTV integration site family, member 8B [KO:K00714]
            216795  Wnt9a; wingless-type MMTV integration site family, member 9A [KO:K01064]
            22412  Wnt9b; wingless-type MMTV integration site family, member 9B [KO:K01064]
            22410  Wnt10b; wingless-type MMTV integration site family, member 10B [KO:K01357]
            22409  Wnt10a; wingless-type MMTV integration site family, member 10A [KO:K01357]
            22411  Wnt11; wingless-type MMTV integration site family, member 11 [KO:K01384]
            93735  Wnt16; wingless-type MMTV integration site family, member 16 [KO:K01558]
            14362  Fzd1; frizzled class receptor 1 [KO:K02432]
            14369  Fzd7; frizzled class receptor 7 [KO:K02432]
            57265  Fzd2; frizzled class receptor 2 [KO:K02235]
            14365  Fzd3; frizzled class receptor 3 [KO:K02329]
            14366  Fzd4; frizzled class receptor 4 [KO:K02354]
            14367  Fzd5; frizzled class receptor 5 [KO:K02375]
            14370  Fzd8; frizzled class receptor 8 [KO:K02375]
            14368  Fzd6; frizzled class receptor 6 [KO:K02376]
            93897  Fzd10; frizzled class receptor 10 [KO:K02842]
            14371  Fzd9; frizzled class receptor 9 [KO:K02842]
            16973  Lrp5; low density lipoprotein receptor-related protein 5 [KO:K03068]
            16974  Lrp6; low density lipoprotein receptor-related protein 6 [KO:K03068]
            13544  Dvl3; dishevelled segment polarity protein 3 [KO:K02353]
            13542  Dvl1; dishevelled segment polarity protein 1 [KO:K02353]
            13543  Dvl2; dishevelled segment polarity protein 2 [KO:K02353]
            14296  Frat1; frequently rearranged in advanced T cell lymphomas [KO:K03069]
            27412  Peg12; paternally expressed 12 [KO:K03069]
            212398  Frat2; frequently rearranged in advanced T cell lymphomas 2 [KO:K03096]
            56637  Gsk3b; glycogen synthase kinase 3 beta [KO:K03083] [EC:2.7.11.26]
            12005  Axin1; axin 1 [KO:K02157]
            12006  Axin2; axin 2 [KO:K04385]
            11789  Apc; APC, WNT signaling pathway regulator [KO:K02085]
            23805  Apc2; APC regulator of WNT signaling pathway 2 [KO:K02085]
            12387  Ctnnb1; catenin (cadherin associated protein), beta 1 [KO:K02105]
            93687  Csnk1a1; casein kinase 1, alpha 1 [KO:K08957] [EC:2.7.11.1]
            21414  Tcf7; transcription factor 7, T cell specific [KO:K02620]
            21415  Tcf7l1; transcription factor 7 like 1 (T cell specific, HMG box) [KO:K04490]
            21416  Tcf7l2; transcription factor 7 like 2, T cell specific, HMG box [KO:K04491]
            16842  Lef1; lymphoid enhancer binding factor 1 [KO:K04492]
            50868  Keap1; kelch-like ECH-associated protein 1 [KO:K10456]
            18024  Nfe2l2; nuclear factor, erythroid derived 2, like 2 [KO:K05638]
            15368  Hmox1; heme oxygenase 1 [KO:K00510] [EC:1.14.14.18]
            18104  Nqo1; NAD(P)H dehydrogenase, quinone 1 [KO:K00355] [EC:1.6.5.2]
            14858  Gsta2; glutathione S-transferase, alpha 2 (Yc2) [KO:K00799] [EC:2.5.1.18]
            14859  Gsta3; glutathione S-transferase, alpha 3 [KO:K00799] [EC:2.5.1.18]
            14860  Gsta4; glutathione S-transferase, alpha 4 [KO:K00799] [EC:2.5.1.18]
            14862  Gstm1; glutathione S-transferase, mu 1 [KO:K00799] [EC:2.5.1.18]
            14863  Gstm2; glutathione S-transferase, mu 2 [KO:K00799] [EC:2.5.1.18]
            14866  Gstm5; glutathione S-transferase, mu 5 [KO:K00799] [EC:2.5.1.18]
            14867  Gstm6; glutathione S-transferase, mu 6 [KO:K00799] [EC:2.5.1.18]
            14871  Gstt1; glutathione S-transferase, theta 1 [KO:K00799] [EC:2.5.1.18]
            14872  Gstt2; glutathione S-transferase, theta 2 [KO:K00799] [EC:2.5.1.18]
            14873  Gsto1; glutathione S-transferase omega 1 [KO:K00799] [EC:2.5.1.18]
            14864  Gstm3; glutathione S-transferase, mu 3 [KO:K00799] [EC:2.5.1.18]
            66447  Mgst3; microsomal glutathione S-transferase 3 [KO:K00799] [EC:2.5.1.18]
            14857  Gsta1; glutathione S-transferase, alpha 1 (Ya) [KO:K00799] [EC:2.5.1.18]
            56615  Mgst1; microsomal glutathione S-transferase 1 [KO:K00799] [EC:2.5.1.18]
            68214  Gsto2; glutathione S-transferase omega 2 [KO:K00799] [EC:2.5.1.18]
            68312  Gstm7; glutathione S-transferase, mu 7 [KO:K00799] [EC:2.5.1.18]
            14865  Gstm4; glutathione S-transferase, mu 4 [KO:K00799] [EC:2.5.1.18]
            211666  Mgst2; microsomal glutathione S-transferase 2 [KO:K00799] [EC:2.5.1.18]
            103140  Gstt3; glutathione S-transferase, theta 3 [KO:K00799] [EC:2.5.1.18]
            75886  Gstt4; glutathione S-transferase, theta 4 [KO:K00799] [EC:2.5.1.18]
            14870  Gstp1; glutathione S-transferase, pi 1 [KO:K23790] [EC:2.5.1.18]
            14869  Gstp2; glutathione S-transferase, pi 2 [KO:K23790] [EC:2.5.1.18]
            225884  Gstp3; glutathione S-transferase pi 3 [KO:K23790] [EC:2.5.1.18]
            50493  Txnrd1; thioredoxin reductase 1 [KO:K22182] [EC:1.8.1.9]
            232223  Txnrd3; thioredoxin reductase 3 [KO:K22182] [EC:1.8.1.9]
            26462  Txnrd2; thioredoxin reductase 2 [KO:K22182] [EC:1.8.1.9]
            15234  Hgf; hepatocyte growth factor [KO:K05460]
            17295  Met; met proto-oncogene [KO:K05099] [EC:2.7.10.1]
            14388  Gab1; growth factor receptor bound protein 2-associated protein 1 [KO:K09593]
            11465  Actg1; actin, gamma, cytoplasmic 1 [KO:K05692]
            11461  Actb; actin, beta [KO:K05692]
            56456  Actl6a; actin-like 6A [KO:K11340]
            83766  Actl6b; actin-like 6B [KO:K11652]
            83797  Smarcd1; SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1 [KO:K11650]
            83796  Smarcd2; SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2 [KO:K11650]
            66993  Smarcd3; SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3 [KO:K11650]
            72057  Phf10; PHD finger protein 10 [KO:K22197]
            29861  Dpf1; D4, zinc and double PHD fingers family 1 [KO:K22198]
            70127  Dpf3; D4, zinc and double PHD fingers, family 3 [KO:K22198]
            239985  Arid1b; AT rich interactive domain 1B (SWI-like) [KO:K11653]
            93760  Arid1a; AT rich interactive domain 1A (SWI-like) [KO:K11653]
            57376  Smarce1; SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1 [KO:K11651]
            20587  Smarcb1; SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1 [KO:K11648]
            20588  Smarcc1; SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1 [KO:K11649]
            68094  Smarcc2; SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 2 [KO:K11649]
            67155  Smarca2; SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 [KO:K11647] [EC:3.6.4.-]
            20586  Smarca4; SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 [KO:K11647] [EC:3.6.4.-]
            77044  Arid2; AT rich interactive domain 2 (ARID, RFX-like) [KO:K11765]
            66923  Pbrm1; polybromo 1 [KO:K11757]
            26992  Brd7; bromodomain containing 7 [KO:K11723]
COMPOUND    C00027  Hydrogen peroxide
            C00039  DNA
            C00076  Calcium cation
            C00165  Diacylglycerol
            C00533  Nitric oxide
            C00704  Superoxide
            C01245  D-myo-Inositol 1,4,5-trisphosphate
            C01471  Acrolein
            C05981  Phosphatidylinositol-3,4,5-trisphosphate
            C06793  Vinyl chloride
            C06800  Aflatoxin B1
            C16844  Hydroxyl radical
            C21641  Hydroperoxyl radical
            C21642  4-Hydroxynonenal
REFERENCE   PMID:20639898
  AUTHORS   Whittaker S, Marais R, Zhu AX
  TITLE     The role of signaling pathways in the development and treatment of hepatocellular carcinoma.
  JOURNAL   Oncogene 29:4989-5005 (2010)
            DOI:10.1038/onc.2010.236
REFERENCE   PMID:26099527
  AUTHORS   Zucman-Rossi J, Villanueva A, Nault JC, Llovet JM
  TITLE     Genetic Landscape and Biomarkers of Hepatocellular Carcinoma.
  JOURNAL   Gastroenterology 149:1226-1239.e4 (2015)
            DOI:10.1053/j.gastro.2015.05.061
REFERENCE   PMID:17295177
  AUTHORS   Villanueva A, Newell P, Chiang DY, Friedman SL, Llovet JM.
  TITLE     Genomics and signaling pathways in hepatocellular carcinoma.
  JOURNAL   Semin Liver Dis 27:55-76 (2007)
            DOI:10.1055/s-2006-960171
REFERENCE   PMID:16799620
  AUTHORS   Breuhahn K, Longerich T, Schirmacher P
  TITLE     Dysregulation of growth factor signaling in human hepatocellular carcinoma.
  JOURNAL   Oncogene 25:3787-800 (2006)
            DOI:10.1038/sj.onc.1209556
REFERENCE   PMID:19387255
  AUTHORS   Minguez B, Tovar V, Chiang D, Villanueva A, Llovet JM
  TITLE     Pathogenesis of hepatocellular carcinoma and molecular therapies.
  JOURNAL   Curr Opin Gastroenterol 25:186-94 (2009)
            DOI:10.1097/MOG.0b013e32832962a1
REFERENCE   PMID:21829020
  AUTHORS   Kudo M
  TITLE     Signaling pathway and molecular-targeted therapy for hepatocellular carcinoma.
  JOURNAL   Dig Dis 29:289-302 (2011)
            DOI:10.1159/000327562
REFERENCE   PMID:23994386
  AUTHORS   Nault JC, Zucman-Rossi J
  TITLE     Genetics of hepatocellular carcinoma: the next generation.
  JOURNAL   J Hepatol 60:224-6 (2014)
            DOI:10.1016/j.jhep.2013.08.019
REFERENCE   PMID:11935086
  AUTHORS   Rocken C, Carl-McGrath S.
  TITLE     Pathology and pathogenesis of hepatocellular carcinoma.
  JOURNAL   Dig Dis 19:269-78 (2001)
            DOI:10.1159/000050693
REFERENCE   PMID:21303380
  AUTHORS   Cornella H, Alsinet C, Villanueva A
  TITLE     Molecular pathogenesis of hepatocellular carcinoma.
  JOURNAL   Alcohol Clin Exp Res 35:821-5 (2011)
            DOI:10.1111/j.1530-0277.2010.01406.x
REFERENCE   PMID:27895396
  AUTHORS   Niu ZS, Niu XJ, Wang WH
  TITLE     Genetic alterations in hepatocellular carcinoma: An update.
  JOURNAL   World J Gastroenterol 22:9069-9095 (2016)
            DOI:10.3748/wjg.v22.i41.9069
REFERENCE   PMID:11956813
  AUTHORS   Tannapfel A, Wittekind C
  TITLE     Genes involved in hepatocellular carcinoma: deregulation in cell cycling and apoptosis.
  JOURNAL   Virchows Arch 440:345-52 (2002)
            DOI:10.1007/s00428-002-0617-x
REFERENCE   PMID:23426905
  AUTHORS   Shiraha H, Yamamoto K, Namba M
  TITLE     Human hepatocyte carcinogenesis (review).
  JOURNAL   Int J Oncol 42:1133-8 (2013)
            DOI:10.3892/ijo.2013.1829
REFERENCE   PMID:23887712
  AUTHORS   Nault JC, Mallet M, Pilati C, Calderaro J, Bioulac-Sage P, Laurent C, Laurent A, Cherqui D, Balabaud C, Zucman-Rossi J
  TITLE     High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions.
  JOURNAL   Nat Commun 4:2218 (2013)
            DOI:10.1038/ncomms3218
REFERENCE   PMID:22561517
  AUTHORS   Guichard C, Amaddeo G, Imbeaud S, Ladeiro Y, Pelletier L, Maad IB, Calderaro J, Bioulac-Sage P, Letexier M, Degos F, Clement B, Balabaud C, Chevet E, Laurent A, Couchy G, Letouze E, Calvo F, Zucman-Rossi J
  TITLE     Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma.
  JOURNAL   Nat Genet 44:694-8 (2012)
            DOI:10.1038/ng.2256
REFERENCE   
  AUTHORS   Praslicka BJ, Kerins MJ, Ooi A
  TITLE     The complex role of NRF2 in cancer: a genomic view
  JOURNAL   Current Opinion in Toxicology 1:37-45 (2016)
            DOI:10.1016/j.cotox.2016.09.003
REFERENCE   PMID:24024136
  AUTHORS   Kansanen E, Kuosmanen SM, Leinonen H, Levonen AL
  TITLE     The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer.
  JOURNAL   Redox Biol 1:45-9 (2013)
            DOI:10.1016/j.redox.2012.10.001
REFERENCE   PMID:21251164
  AUTHORS   Taguchi K, Motohashi H, Yamamoto M
  TITLE     Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution.
  JOURNAL   Genes Cells 16:123-40 (2011)
            DOI:10.1111/j.1365-2443.2010.01473.x
REFERENCE   PMID:20019356
  AUTHORS   Klaunig JE, Kamendulis LM, Hocevar BA
  TITLE     Oxidative stress and oxidative damage in carcinogenesis.
  JOURNAL   Toxicol Pathol 38:96-109 (2010)
            DOI:10.1177/0192623309356453
REFERENCE   PMID:11193292
  AUTHORS   Krupp G, Bonatz G, Parwaresch R
  TITLE     Telomerase, immortality and cancer.
  JOURNAL   Biotechnol Annu Rev 6:103-40 (2000)
            DOI:10.1016/S1387-2656(00)06020-8
REFERENCE   PMID:27323951
  AUTHORS   Jafri MA, Ansari SA, Alqahtani MH, Shay JW
  TITLE     Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies.
  JOURNAL   Genome Med 8:69 (2016)
            DOI:10.1186/s13073-016-0324-x
REFERENCE   PMID:27029895
  AUTHORS   Shay JW
  TITLE     Role of Telomeres and Telomerase in Aging and Cancer.
  JOURNAL   Cancer Discov 6:584-93 (2016)
            DOI:10.1158/2159-8290.CD-16-0062
REFERENCE   PMID:27508192
  AUTHORS   Granito A, Guidetti E, Gramantieri L
  TITLE     c-MET receptor tyrosine kinase as a molecular target in advanced hepatocellular carcinoma.
  JOURNAL   J Hepatocell Carcinoma 2:29-38 (2015)
            DOI:10.2147/JHC.S77038
REFERENCE   PMID:16934487
  AUTHORS   Vita M, Henriksson M
  TITLE     The Myc oncoprotein as a therapeutic target for human cancer.
  JOURNAL   Semin Cancer Biol 16:318-30 (2006)
            DOI:10.1016/j.semcancer.2006.07.015
REFERENCE   PMID:24096051
  AUTHORS   Qu A, Jiang C, Cai Y, Kim JH, Tanaka N, Ward JM, Shah YM, Gonzalez FJ
  TITLE     Role of Myc in hepatocellular proliferation and hepatocarcinogenesis.
  JOURNAL   J Hepatol 60:331-8 (2014)
            DOI:10.1016/j.jhep.2013.09.024
REL_PATHWAY mmu04010  MAPK signaling pathway
            mmu04020  Calcium signaling pathway
            mmu04110  Cell cycle
            mmu04115  p53 signaling pathway
            mmu04151  PI3K-Akt signaling pathway
            mmu04310  Wnt signaling pathway
            mmu04350  TGF-beta signaling pathway
            mmu04932  Non-alcoholic fatty liver disease (NAFLD)
            mmu05160  Hepatitis C
            mmu05161  Hepatitis B
KO_PATHWAY  ko05225
///
